RCS - Avingtrans PLC - Medical & Industrial Imaging Division Appointment

AvingtransAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260112:nRSL4060Oa&default-theme=true

RNS Number : 4060O  Avingtrans PLC  12 January 2026

12 January 2026

 

Avingtrans plc

 

("Avingtrans", the "Company", or the "Group")

 

Avingtrans Medical & Industrial Imaging Division Appointment

 

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical
components, modules, systems and associated services to the energy, medical
and industrial sectors, is pleased to announce that Stuart Gall officially
started his role as Chief Executive Officer of the Avingtrans medical and
industrial imaging division on 1 January 2026.

 

Stuart brings a wealth of experience in scaling medical technology companies
from innovation to market adoption. He was one of the three founding directors
of AIM listed university commercialisation company Fusion IP, that was
acquired by IP Group plc for £103m in 2014 and most recently, Chief Executive
Officer of AIM listed Intelligent Ultrasound Group plc (AIM: IUG), the medical
imaging AI software and simulation vendor, whose AI software operation was
sold to GEHC for £40m in 2024 and the remaining simulation business was sold
to Surgical Science Sweden AB in February 2025.

 

Under his leadership, Intelligent Ultrasound transitioned from a university
MedTech spin-out to a publicly listed company with global partnerships in both
medical education and clinical AI.

 

At Avingtrans, Stuart will oversee the strategic development and
commercialisation of Adaptix and the Magnetica Group. Adaptix is a pioneering
low-dose, point-of-care 3D X-ray imaging company, Magnetica is focused on the
development of compact, helium-free MRI systems, and Scientific Magnets is a
world leader in the design, manufacture and installation of bespoke
cryogen-free superconducting magnets.

 

Stuart Gall commented: "Avingtrans has an exciting portfolio of companies with
world-class disruptive technologies that could transform a number of key
medical and industrial imaging markets, and I look forward to working with the
respective teams to accelerate their commercial adoption and enhance their
value to shareholders."

 

Steve McQuillan, CEO of Avingtrans plc, added: "We are delighted Stuart has
been able to start his role earlier than originally notified to the market and
his proven track record in guiding technology companies from early innovation
through to commercial success will be invaluable as we continue to build the
value of our medical and industrial imaging division."

 

Enquiries:

 

 Avingtrans plc                                          01354 692 391
 Roger McDowell, Chairman

 Steve McQuillan, Chief Executive Officer

 Stephen King, Chief Financial Officer

 Singer Capital Markets (Nominated Adviser and Broker)   020 7496 3000
 Sara Hale

 Alex Bond

 IFC Advisory (Financial PR)                             020 3934 6630
 Graham Herring

 Tim Metcalfe

 Zach Cohen

 

About Avingtrans plc:

 

Avingtrans designs, manufactures and supplies original equipment, systems and
associated aftermarket services to the energy, medical and industrial markets
worldwide.

 

Business units

 

 Hayward Tyler - Luton, East Kilbride UK, USA, China and India

 Specialises in the design, manufacture and servicing of performance-critical
 motors and pumps for challenging environments.

 Energy Steel, Inc - Rochester Hills, Michigan, USA

 Provider of custom fabrications for the nuclear industry, specialising in: OEM
 parts obsolescence; custom fabrications; engineering design solutions; product
 refurbishment; on-site technical support.

 Stainless Metalcraft Ltd - Chatteris, UK

 Provider of safety-critical equipment for the energy, medical, science and
 research communities, worldwide, specialising in precision pressure and vacuum
 vessels and associated fabrications, sub-assemblies and systems.

 Booth Industries - Bolton, UK

 Designs, manufactures, installs and services doors and walls which can be
 tailored to be: blast and explosion proof; fireproof; acoustically shielded;
 high security/safety; or combinations of the above.

 Ormandy Group - Bradford, UK

 Design, manufacturers and servicing of off-site plant, heat exchangers and
 other HVAC (heating, ventilation and air conditioning) products.

 Slack & Parr - Kegworth, UK, USA & China

 Design, manufacture and servicing of high-precision gear metering pumps,
 hydraulics flow dividers and industrial pumps.

 Composite Products Ltd - Buckingham, UK

 Centre for composite technology, parts and assemblies, serving customers in
 industrial markets.

 Adaptix Ltd - Oxford, UK

 Adaptix has developed novel 3D X-ray for Orthopaedic and Veterinary
 applications amongst others. Commercialisation of this system (and others) is
 on-going.

 Magnetica Ltd - Brisbane, Australia

 Magnetica Limited specialises in the development of next generation MRI
 technologies, including dedicated extremity MRI systems and MRI system
 components. Magnetica has successfully built and tested a compact, integrated
 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging.
 Commercialisation of this system (and others) is on-going. Magnetica's
 structure now includes two other business units:

 Scientific Magnetics - Abingdon, UK

 Designs and manufactures superconducting magnet systems and associated
 cryogenics for a variety of markets including MRI and provides services for
 Nuclear Magnetic Resonance instruments.

 Tecmag Inc - Houston, USA

 Designs, manufactures and installs instrumentation, including consoles, system
 upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear
 Magnetic Resonance (NMR) systems.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRASSMFWUEMSEFF



            Copyright 2019 Regulatory News Service, all rights reserved